• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconRoche

Roche

Page 3 of 4
Sarepta Stock Roche Deal
Health
Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
By Sy MukherjeeDecember 23, 2019
FDA drug approvals Roche Celgene AbbVie
Newsletters
The FDA Went on an Epic Drug Approval Binge This Week: Brainstorm Health
By Sy MukherjeeAugust 16, 2019
Pipette adding sample to petri dish with DNA profiles in background
Health
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist Spark
By Tim Loh, Naomi Kresge and BloombergFebruary 25, 2019
Genentech new flu drug
Health
The FDA Approved the First Big New Flu Drug in Almost 20 Years—And Is Approaching a Drug Approval Record
By Sy MukherjeeOctober 24, 2018
How to Innovate at Flatiron Health? It Starts With a Hackathon
Health
How to Innovate at Flatiron Health? It Starts With a Hackathon
By Andrew NuscaJuly 31, 2018
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
Health
Japan Just Approved a New Drug That Can Kill the Flu Virus In Just One Day
By Sy MukherjeeFebruary 23, 2018
female scientist pipetting gel into machine
Health
Why Drug Giant Roche’s $1.9 Billion Deal to Buy Data Startup Flatiron Health Matters
By Sy MukherjeeFebruary 16, 2018
Roche Holding AG Annual New Conference
Finance
Roche to Buy U.S. Cancer Drugmaker Ignyta for $1.7 Billion
By BloombergDecember 22, 2017
Huntington's Disease
Health
A ‘Groundbreaking’ New Drug Shows Promise Against Huntington’s—But There’s a Catch
By Sy MukherjeeDecember 11, 2017
An Amgen sign is seen at the company's office in South San Francisco
Health
Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By Sy MukherjeeSeptember 15, 2017
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
Roche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By Sy MukherjeeJune 5, 2017
Walker For Handicapped Person
Health
The FDA Just Approved the First Ever Drug to Treat Severe MS
By Sy MukherjeeMarch 29, 2017
Roche Holding AG Chief Executive Officer Severin Schwan Attends Company's Media Briefing
Leadership
This Big Pharma CEO Thinks Trump’s Drug Pricing Threats Are All Bark and No Bite
By Sy MukherjeeFebruary 2, 2017
The Food and Drug Administration
Health
The FDA Has Issued Emergency Authorization for Roche’s Zika Test
By Reuters and Michelle TohAugust 29, 2016
Bottles of Merck & Co.'s cervical cancer vaccine Gardasil ar
Health
Here’s Why HPV-Related Cancers Are Rising Among American Men
By Sy MukherjeeJuly 8, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Today, Emily Blunt is worth $80 million thanks to her Hollywood career—but she actually wanted to be a UN Spanish translator on $80Kplaceholder alt text
By Orianna Rosa RoyleJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.